Impact of heart failure unit complexity in the treatment with intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: Insights from the LEVO-D Registry
Event:
Heart Failure 2022
Topic:
Pharmacotherapy
Session:
Heart Failure ePosters - focus on Chronic Heart Failure 8